Klotz U, Reimann I
Klin Wochenschr. 1983 Jul 1;61(13):625-32. doi: 10.1007/BF01487578.
H2-blocking agents, such as cimetidine or ranitidine are used in numerous patients. This treatment is often associated with the co-administration of a variety of other drugs. From clinical observations and pharmacokinetic studies it is obvious that even short-term treatment with therapeutic doses of cimetidine inhibits the hepatic elimination of antipyrine, warfarin, diazepam, desmethyldiazepam, chlordiazepoxide, propranolol, labetalol, metoprolol, phenytoin, carbamazepine, chlormethiazole, theophylline and caffeine. All these drugs are metabolized by cytochrome-dependent so-called phase I reactions. Cimetidine can interact with drug binding to the cytochrome P450 system leading to impaired drug metabolism. On the other hand drugs which are eliminated by glucuronidation (cytochrome independent phase II reaction), such as oxazepam and lorazepam are not affected by cimetidine. Other H2-blocking agents (ranitidine, oxmetidine) did not impair the elimination of antipyrine, warfarin, diazepam or propranolol. Furthermore, cimetidine and ranitidine might slightly reduce hepatic blood flow which could reduce the elimination of drugs with high hepatic clearance.
H2受体阻滞剂,如西咪替丁或雷尼替丁,被大量患者使用。这种治疗通常与多种其他药物联合使用。从临床观察和药代动力学研究中可以明显看出,即使是用治疗剂量的西咪替丁进行短期治疗,也会抑制安替比林、华法林、地西泮、去甲西泮、氯氮卓、普萘洛尔、拉贝洛尔、美托洛尔、苯妥英、卡马西平、氯美噻唑、茶碱和咖啡因的肝脏清除。所有这些药物都是通过细胞色素依赖性的所谓I相反应进行代谢的。西咪替丁可与药物与细胞色素P450系统的结合相互作用,导致药物代谢受损。另一方面,通过葡萄糖醛酸化消除的药物(细胞色素非依赖性II相反应),如奥沙西泮和劳拉西泮,不受西咪替丁影响。其他H2受体阻滞剂(雷尼替丁、奥美替丁)不会损害安替比林、华法林、地西泮或普萘洛尔的清除。此外,西咪替丁和雷尼替丁可能会轻微降低肝血流量,这可能会减少高肝清除率药物的清除。